Deep Brain Stimulation in Patients Suffering from Movement Disorders – Stereotactic Procedure and Intraoperative Findings

Česká verzia

Authors: D. Urgošík ^1,2; R. Jech ²; E. Růžička ²
Authors place of work: Odd. stereotaktické a radiační neurochirurgie, Nemocnice Na Homolce, Praha ¹; Neurologická klinika a Centrum klinických neurověd1. LF UK a VFN v Praze ²
Published in the journal: Cesk Slov Neurol N 2011; 74/107(2): 175-186
Category: Original Paper

Summary

Introduction:
Deep brain stimulation (DBS) is the method of choice in the treatment of various movement disorders.

Methods:
Between 1998 and 2009, we performed DBS in 100 patients (F : M = 37 : 63; median 56 yrs /12–73 yrs/). Fourteen patients suffered from essential tremor (ET), 2 from tremor of other aetiology (T), 73 from Parkinson’s disease (PD), 10 from generalized (GD) and 1 from cervical (CD) dystonia. Implantation was targeted in the ventral intermedial thalamus (VIM) for ET, T and PD, subthalamic nucelus (STN) for PD and internal pallidum (GPi) for GD, CD and PD. Intracerebral electrodes were totally implanted into 187 nuclei. We evaluated stimulation parameters, while clinical response and parameters determined the accuracy of implantation.

Results:
The lowest effective amplitude of stimulation ranged from 0.3 to 2.5 V (median 1 V). The therapeutic interval ranged from 0 to 5 V (median 2.5 V). Tremor was eliminated in 92.9% of cases, rigidity in 94.7% and akinesia in 18.9%. The central trajectory was used for final electrode implantation in 56.7% of procedures. In STN the trajectory passed through the nucleus in the range of 3.5–7.5 mm (median 5 mm). The difference of coordinates between expected and real position of electrodes was: ΔX = 0.5 (0–1.5), ΔY = 0.7 (0–1.7), ΔZ = 0.5 (0–1.7). The most frequent side effects were paraesthesias (VIM 38%) and dysarthria (STN 28.3%). Overall morbidity occurred in 21% of patients.

Conclusion:
The results showed accurate targeting and optimal implantation technique with minimal morbidity.

Key words:
deep brain stimulation – Parkinson’s disease – dystonia – tremor – intraoperative results – accuracy of implantation – intraoperative complication

Zdroje

1. Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 1987; 50(1–6): 344–346.

2. Blond S, Siegfried J. Thalamic stimulation for the treatment of tremor and other movement disorders. Acta Neurochir (Wien) 1991; 52: 109–111.

3. Benabid AL, Pollak P, Gervason C, Hoffmann D, Gao DM, Hommel M et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991; 337(8738): 403–406.

4. Siegfried J. Therapeutic stereotactic procedures on the thalamus for motor movement disorders. Acta Neurochir (Wien) 1993; 124(1): 14–18.

5. Pollak P, Benabid AL, Gross C, Gao DM, Laurent A, Benazzouz A et al. Effects of the stimulation of the subthalamic nucleus in Parkinson disease. Rev Neurol (Paris) 1993; 149(3): 175–176.

6. Siegfried J, Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 1994; 35(6): 1126–1129.

7. Benabid AL, Pollak P, Gross C, Hoffmann D, Benazzouz A, Gao DM et al. Acute and long-term effects of subthalamic nucleus stimulation in Parkinson‘s disease. Stereotact Funct Neurosurg 1994; 62(1–4): 76–84.

8. Coubes P, Cif L, El Fertit H, Hemm S, Vayssiere N, Serrat S et al. Electrical stimulation of the globus pallidus internus in patients with primary generalized dystonia: long-term results. J Neurosurg 2004; 101(2): 189–194.

9. Castelnau P, Cif L, Valente EM, Vayssiere N, Hemm S, Gannau A et al. Pallidal stimulation improves pantothenate kinase-associated neurodegeneration. Ann Neurol 2005; 57(5): 738–741.

10. Krause M, Fogel W, Tronnier V, Pohle S, Hörtnagel K, Thyen U et al. Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration. Mov Disord 2006; 21(12): 2255–2257.

11. Uc EY, Follett KA. Deep brain stimulation in movement disorders. Semin Neurol 2007; 27(2): 170–182.

12. Ruzicka E, Jech R, Zarubova K, Roth J, Urgosik D. VIM thalamic stimulation for tremor in a patient with IgM paraproteinaemic demyelinating neuropathy. Mov Disord 2003; 18(10): 1192–1195.

13. Volkmann J, Sturm V, Weiss P, Kappler J, Voges J, Koulousakis A et al. Bilateral high-frequency stimulation of the internal globus pallidus in advanced Parkinson’s disease. Ann Neurol 1998; 44(6): 953–961.

14. Růžička E, Urgošík D, Jech R, Serranová T, Volfová M, Roth J et al. Hluboká mozková stimulace v léčbě Parkinsonovy nemoci a třesu: Pražská zkušenost 1998–2003. Cesk Slov Neurol N 2004; 67/100(6): 423–436.

15. Lang AE, Houeto JL, Krack P, Kubu C, Lyons KE, Moro E et al. Deep brain stimulation: preoperative issues. Mov Disord 2006; 21 (Suppl 14): S171–S196.

16. Fahn S, Tolosa E, Maria C. Clinical rating scale for tremor. In: Jankovic J, Tolosa E (eds). Parkinson’s disease and movement disorders. Baltimore: Williams and Wilkins 1993: 271–280.

17. Novotny J jr, Vymazal J, Novotny J, Tlachacova D, Schmitt M, Chuda P et al. Does new magnetic resonance imaging technology provide better geometrical accuracy during stereotactic imaging? J Neurosurg 2005; 102 (Suppl): 8–13.

18. Schaltenbrand G, Wahren W. Atlas for stereotaxy of the human brain. Stuttgart: Georg Thieme Publishers 1977.

19. Benazzouz A, Breit S, Koudsie A, Pollak P, Krack P, Benabid AL. Intraoperative microrecordings of the subthalamic nucleus in Parkinson‘s disease. Mov Disord 2002; 17 (Suppl 3): S145–S149.

20. Guridi J, Rodriguez-Oroz MC, Lozano AM, Moro E, Albanese A, Nuttin B et al. Targeting the basal ganglia for deep brain stimulation in Parkinson’s disease. Neurology 2000; 55 (Suppl 6): S21–S28.

21. Senatus PB, Teeple D, McClelland S III, Pullman SL, Yu Q, Ford B et al. A technique for minimally altering anatomically based subthalamic electrode targeting by microelectrode recording. Neurosurg Focus 2006; 20(5): E8.

22. Amirnovin R, Williams ZM, Cosgrove GR, Eskandar EN. Experience with microelectrode guided subthalamic nucleus deep brain stimulation. Neurosurgery 2006; 58 (Suppl 1): ONS96–ONS102.

23. Hamid NA, Mitchell RD, Mocroft P, Westby GW, Milner J, Pall H. Targeting the subthalamic nucleus for deep brain stimulation: technical approach and fusion of pre- and postoperative MR images to define accuracy of lead placement. J Neurol Neurosurg Psychiatry 2005; 76(3): 409–414.

24. McClelland S III, Ford B, Senatus PB, Winfield LM, Du YE, Pullman SL et al. Subthalamic stimulation for Parkinson disease: determination of electrode location necessary for clinical efficacy. Neurosurg Focus 2005; 19(5): E12.

25. Andrade-Souza YM, Schwalb JM, Hamani C, Eltahawy H, Hoque T, Saint-Cyr J et al. Comparison of three methods of targeting the subthalamic nucleus for chronic stimulation in Parkinson‘s disease. Neurosurgery 2005; 56 (Suppl 2): 360–368.

26. Breit S, Pegas JF, Koudsie A, Schulz J, Benazzouz A, Pollak P et al. Pretargeting for the implantation of stimulation electrodes into the subthalamic nucleus: a komparative study of magnetic resonance imaging and ventriculography. Neurosurgery 2006; 58 (Suppl 1): ONS83–ONS95.

27. McClelland S III, Kim B, Winfield LM, Ford B, Edwards TA, Pulman SL et al. Microelectrode recording-determined subthalamic nucleus length not predictive of stimulation-induced side effects. Neurosurg Focus 2005; 19(5): E13.

28. Gross RE, Krack P, Rodriguez-Oroz MC, Rezai AR, Benabid AL. Electrophysiological mapping for the implantation of deep brain stimulators for Parkinson‘s disease and tremor. Mov Disord 2006; 21 (Suppl 14): S259–S283.

29. Pollak P, Krack P, Fraix V, Mendes A, Moro E, Chabardes S et al. Intraoperative micro- and macrostimulation of the subthalamic nucleus in Parkinson’s disease. Mov Disord 2002; 17 (Suppl 3): S155–S161.

30. Steigerwald F, Volkmann J. Intra-operative Microrecording and Stimulation. In: Tarsy D, Vitek JL, Starr PA, Okun MS (eds). Deep Brain Stimulation in Neurological and Psychiatric Disorders. Serie: Current Clinical Neurology. Totowa, NJ, USA: Humana Press 2008: 111–134.

31. Macchi G, Jones EG. Toward an agreement on terminology of nuclear and subnuclear divisions of the motor thalamus. J Neurosurg 1997; 86(4): 670–685.

32. Goodman RR, Kim B, McClelland S III, Senatus PB, Winfield LM, Pullman SL et al. Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry 2006; 77(1): 12–17.

33. Seijo FJ, Alvarez-Vega MA, Gutierrez JC, Fdez-Glez F, Lozano B. Complications in subthalamic nucleus stimulation surgery for treatment of Parkinson’s disease. Review of 272 procedures. Acta Neurochir (Wien) 2007; 149(9): 867–875.

34. Vesper J, Haak S, Ostertag C, Nikkhah G. Subthalamic nucleus deep brain stimulation in elderly patients – analysis of outcome and complications. BMC Neurol 2007; 7: 7.

35. Herzog J, Volkmann J, Krack P, Kopper F, Pötter M, Lorenz D et al. Two-year follow-up of subthalamic deep brain stimulation in Parkinson’s disease. Mov Disord 2003; 18(11): 1332–1337.

36. Rezai AR, Kopell BH, Gross RE, Vitek JL, Sharan AD, Limousin P et al. Deep brain stimulation for Parkinson’s disease: surgical issues. Mov Disord 2006; 21 (Suppl 14): S197–S218.

37. Oh MY, Abosch A, Kim SH, Lang AE, Lozano AM. Long-term hardware-related complications of deep brain stimulation. Neurosurgery 2002; 50(6):1268–1274.

38. Beric A, Kelly PJ, Rezai A, Sterio D, Mogilner A, Zonenshayn M, Kopell B. Complications of deep brain stimulation surgery. Stereotact Funct Neurosurg 2001; 77(1–4): 73–78.

39. Blomstedt P, Hariz MI. Hardware-related complications of deep brain stimulation: a ten year experience. Acta Neurochir (Wien) 2005; 147(10): 1061–1064.

40. Sixel-Döring F, Trenkwalder C, Kappus C, Hellwig D. Skin complications in deep brain stimulation for Parkinson’s disease: frequency, time course, and risk factors. Acta Neurochir (Wien) 2010; 152(2):195–200.

41. Jech R, Urgosik D, Tintera J, Nebuzelsky A, Krasensky J, Liscak R et al. Functional magnetic resonance imaging during deep brain stimulation: a pilot study in four patients with Parkinson‘s disease. Mov Disord 2001; 16(6): 1126–1132.